Pks ongs

HomeChartsBillboard Canadian Hot 100APT.ROSE & Bruno MarsLAST WEEK 1 PEAK POSITION 1 WEEKS ON CHART 21 Die With A SmileLady Gaga & Bruno MarsLAST WEEK 2 PEAK POSITION 1 WEEKS ON CHART 30 That's So TrueGracie AbramsLAST WEEK 3 PEAK POSITION 1 WEEKS ON CHART 21 Billboard Canadian AlbumsMAYHEMLady GagaSo Close To WhatTate McRae$ome $exy $ongs 4 UPARTYNEXTDOOR & DrakeBillboard Hot 100LutherKendrick Lamar & SZADie With A SmileLady Gaga & Bruno MarsNot Like UsKendrick LamarBillboard 200MAYHEMLady GagaGNXKendrick Lamar$ome $exy $ongs 4 UPARTYNEXTDOOR & DrakeBillboard Global 200Die With A SmileLady Gaga & Bruno MarsAPT.ROSE & Bruno MarsLutherKendrick Lamar & SZABillboard Global Excl. USDie With A SmileLady Gaga & Bruno MarsAPT.ROSE & Bruno Marslike JENNIEJENNIE Canadian Airplay Charts All Format AirplayLove SomebodyMorgan WallenStargazingMyles SmithAPT.ROSE & Bruno MarsAC AirplayStargazingMyles SmithI Had Some HelpPost Malone Featuring Morgan WallenBeautiful ThingsBenson BooneCHR AirplayThat's So TrueGracie AbramsPink Pony ClubChappell RoanMessyLola YoungHot AC AirplayDie With A SmileLady Gaga & Bruno MarsStargazingMyles SmithThat's So TrueGracie AbramsCountry AirplayI Ain't Sayin'Jordan Davis4x4xULainey WilsonLiarJelly RollMainstream Rock AirplayMaydayThree Days GraceDance, Kid, DanceShinedownSad In CarolinaDexter And The MoonrocksModern Rock AirplayNobody's SoldierHozierMess To MakeJJ WildeMessyLola YoungBILLBOARD CANADA FYI A weekly briefing on what matters in the music industry By signing up you agree to Billboard Canada’s privacy policy.

Home Forum Games Shop Game Keys Dedicated Servers Crypto Exchange The Black Market Register FAQ Today's Posts Search elitepvpers > Popular Games > Silkroad Online Bard Dances You last visited: Today at 10:41 Please register to post and access all features, it's quick, easy and FREE! Advertisement Advertise with us! Discussion on Bard Dances within the Silkroad Online forum part of the Popular Games category. 04/02/2011, 22:42 #1 elite*gold: 0 The Black Market: 1/0/0 Join Date: Feb 2011 Posts: 269 Received Thanks: 25 Bard Dances so I choosed my sub as bard at first time and I don't know how to use those dance skills,it just keep saying "Can only be used withing music play area" and where is that play area? I don't understand 04/02/2011, 22:44 #2 passi27 elite*gold: 0 The Black Market: 6/0/0 Join Date: Jun 2009 Posts: 464 Received Thanks: 67 To use that skills a second bard have to stay in your party 04/02/2011, 22:45 #3 marshalas elite*gold: 0 The Black Market: 1/0/0 Join Date: Feb 2011 Posts: 269 Received Thanks: 25 Quote: Originally Posted by passi27 To use that skills a second bard have to stay in your party and he have to be same lvl use something skill or what? 04/02/2011, 22:56 #4 passi27 elite*gold: 0 The Black Market: 6/0/0 Join Date: Jun 2009 Posts: 464 Received Thanks: 67 Im not sure about that but i think he just have to be a bard, since people use there low chars at ongs to get this skills Thanks 1 User 04/02/2011, 22:57 #5 marshalas elite*gold: 0 The Black Market: 1/0/0 Join Date: Feb 2011 Posts: 269 Received Thanks: 25 Quote: Originally Posted by passi27 Im not sure about that but i think he just have to be a bard, since people use there low chars at ongs to get this skills thanx bro^^EDIT:2 bards in party,still can't use >. 04/02/2011, 23:23 #6 LifeSucKs18 elite*gold: 0 The Black Market: 5/0/0 Join Date: Feb 2009 Posts: 662 Received Thanks: 58 one of the bard gotta use Guard of Tombour or Tombour of Mana then the 2nd bard can use The Dances 04/03/2011, 00:52 #7 greencow elite*gold: 0 The Black Market: 6/0/0 Join Date: May 2009 Posts: 443 Received Thanks: 45 Every Dances has to be used in sync with a *Tambour (*Dont Know Spelling) 04/03/2011, 01:44 #8 Pr0Styla elite*gold: 0 The Black Market: 19/0/1 Join Date: Jan

Flavensomycin, and humidin [74]. Additionally, macrolide antibiotics such as bafilomycins (B1, C1, and D) and hygrobafilomycin, known for their potent antifungal properties, have been associated with S. cavourensis species [75].Genomic analysis provided further insights into the strain’s biosynthetic potential. AntiSMASH analysis predicted secondary metabolic biosynthetic gene clusters (BGCs), including those for polyketide synthases (PKS), nonribosomal peptide synthetases (NRPS), terpenoids, and other classes of bioactive compounds. The presence of multiple BGCs suggests that the strain is capable of producing a wide variety of bioactive compounds, which could be of significant interest for pharmaceutical and industrial applications. In addition, the presence of BGCs with low similarity to known clusters can uncover novel antibiotics and other bioactive molecules with therapeutic potential.Polyketides are a diverse class of secondary metabolites with notable pharmacological activities, including antibiotic, anticancer, and immunosuppressive properties [76]. Notably, one NRPS-T1PKS cluster displayed complete similarity to the biosynthetic gene cluster (BGC) of the flavonoid naringenin, while another NRPS-T3PKS cluster was associated with alkylresorcinol. Although naringenin is primarily known as a plant-derived metabolite, it has recently been identified in a few Streptomyces species [77]. Furthermore, its encoding gene cluster has also been detected in certain Saccharotrix and Kitasatospora species [78]. Several biological activities have been associated with these compounds, including antioxidant, antitumor, antiviral, antibacterial, antifungal, and anti-inflammatory [79]. Additionally, Type II PKS clusters, associated with aromatic polyketides like jadomycin were detected. These clusters employ an iterative mechanism of chain elongation and cyclization, producing highly conjugated and planar structures typical of compounds with antibacterial

And anticancer properties [80]. The identification of Type III PKS clusters, which catalyze the condensation of acyl-CoA precursors without requiring a carrier protein, suggests the strain’s ability to produce simple aromatic polyketides like chalcones and resorcinols, which often serve as precursors for complex natural products or exhibit independent bioactivities [81].The genome annotation reveals the presence of several NRPSs with a range of bioactive properties. Notable examples with high similarity ≥ 50% include alpiniamide and valinomycin/montanastatin, all of which have significant potential [82,83,84]. Other compounds like griseobactin, minimycin, and heat-stable antifungal factor further demonstrate the strain’s ability to produce a variety of peptides with diverse bioactivities, including antibacterial, antifungal, and anticancer activities. Beyond PKS, NRPS, and terpenoid clusters, the genome of Streptomyces sp. ACT158 includes BGCs for RiPPs and siderophores, which contribute to its metabolic versatility and potential bioactivity both antimicrobial and antitumor potential [85]. 5. ConclusionsComparative genomic analysis placed ACT158 within the Streptomyces cavourensis species complex, with ANI and DDH values supporting its taxonomic assignment. Despite its close relationship to other S. cavourensis strains, ACT158 harbors unique gene families, likely contributing to its specialized ecological adaptations and secondary metabolite production capabilities. These unique genetic features emphasize the significance of exploring under-represented environments like wetlands for discovering actinomycetes with novel biosynthetic traits. Overall, Streptomyces sp. ACT158 exemplifies the potential of actinomycetes from unique ecological niches to address critical challenges in medicine and industry. Its phenotypic adaptability, metabolic diversity, and genomic insights indicate its suitability for developing novel bioactive compounds. Future research

The future of wealth management is independent objective specialized client-focused collaborative aligned We empower advisors to elevate their clients' financial futures. We provide bespoke client solutions, curated resources, and robust technology that empower advisors to best serve their clients. Our advisors are the confidants their clients’ trust, and we’re the specialist they need. Safety and security of assetsWe have chosen leading financial institutions to custody and safeguard client assets Best-in-breed technologyOur fully-integrated platform touches every area of an advisor's business and elevates the client experience Range of solutionsWe offer solutions and services to help us achieve client investment and wealth objectives Advice is provided by your advisor Our diverse network of local advisors and their teams are responsible for helping their clients meet their goals and investment objectives. Operating as independent business owners leveraging the Concurrent platform, each partner firm has the opportunity to build its own brand and unique culture and to contribute its expertise to the collective. The platform is provided by Concurrent Concurrent serves as a platform for advisors, providing compliance, supervision, operational support, investment due diligence, technology, and access to leading custodians, a broker-dealer, and banking and trust services.We empower advisors as advocates for their clients, with a complete foundation of support that allows them to run their practice as they desire. Custody/Broker Dealer Privately held for more than 75 years, Fidelity Institutional® is one of the world’s largest and most respected financial services firms, with more than $11 trillion in assets under administration, as of March 2022.As a leading independent broker-dealer, PKS facilitates our ability to conduct commissionable transactions where appropriate. Solutions Our culture of collaboration opens the door to a network of specialists aligned to round out a holistic wealth management experience. Concurrent provides robust support and access to solutions in the areas of: Financial Planning Asset Management Alternative Investments Insurance Technology The Concurrent platform offers you and your advisor best-in-class technology. We believe in the power of partnership Advisors in the Concurrent network have the independence, control, and flexibility to better care for their clients. Assets Under Management $ 1 B What we're up to Stay current Sign up for our latest news and insights. 100 Ashley Drive S, Suite 830 Tampa, FL 33602-5304 T: 813.575.2652 Advisory Services offered through Concurrent Investment Advisors, LLC, an SEC Registered Investment Advisor. Brokerage services offered through Purshe Kaplan Sterling Investments (PKS), Member FINRA/SIPC Headquartered at 80 State Street, Albany, NY 12207. PKS and Concurrent Investment Advisors, LLC are not affiliated companies. These materials have been independently produced by Concurrent. Concurrent is independent of, and has no affiliation with, Charles Schwab & Co., Inc. or any of its affiliates (“Schwab”). Schwab is a registered broker-dealer and member